Paulex Bio
Paulex Bio is a startup headquartered in La Jolla, United States, founded in 2023. It has raised at least $18.5m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Paulex Bio has raised at least $18.5m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Paulex Bio sits inside the San Diego R&D ecosystem in the Global R&D Labs Directory.
Other startups in La Jolla
- A28 Therapeutics
- AeroRx Therapeutics
- Arialys Therapeutics
- DEPTH Health
- Enlaza Therapeutics
- RightDevice
- Sylke
- Valora Therapeutics
Related
- Innovation profile of La Jolla
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Paulex Bio do?
Paulex Bio is classed in pharmaceuticals in its filings with the US Securities and Exchange Commission.
How much has Paulex Bio raised?
At least $18.5m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Paulex Bio based?
Paulex Bio is headquartered in La Jolla, United States.
When was Paulex Bio founded?
Paulex Bio was founded in 2023.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.